Ana Pokrajac

625 total citations
17 papers, 432 citations indexed

About

Ana Pokrajac is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Molecular Biology. According to data from OpenAlex, Ana Pokrajac has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Nephrology and 3 papers in Molecular Biology. Recurrent topics in Ana Pokrajac's work include Diabetes Treatment and Management (7 papers), Chronic Kidney Disease and Diabetes (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Ana Pokrajac is often cited by papers focused on Diabetes Treatment and Management (7 papers), Chronic Kidney Disease and Diabetes (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Ana Pokrajac collaborates with scholars based in United Kingdom, Germany and Serbia. Ana Pokrajac's co-authors include Peter Trainer, Gwen Wark, Damian Fogarty, G Wieringa, Samantha Wilkinson, Laurie A. Tomlinson, Liam Smeeth, Ian Douglas, Heide A. Stirnadel-Farrant and Indranil Dasgupta and has published in prestigious journals such as Clinical Endocrinology, European Journal of Endocrinology and BMJ Open.

In The Last Decade

Ana Pokrajac

16 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Pokrajac United Kingdom 10 352 104 85 53 47 17 432
Yufeng Li China 10 316 0.9× 86 0.8× 154 1.8× 39 0.7× 32 0.7× 28 445
Abhishek Kansara United States 6 225 0.6× 87 0.8× 72 0.8× 21 0.4× 52 1.1× 11 376
Shinji Kamei Japan 11 191 0.5× 105 1.0× 90 1.1× 37 0.7× 30 0.6× 44 356
Aydın Tunçkale Türkiye 12 235 0.7× 164 1.6× 121 1.4× 28 0.5× 30 0.6× 24 435
Steven Sambevski United States 5 336 1.0× 134 1.3× 168 2.0× 48 0.9× 118 2.5× 9 438
Zhenwei Fang China 6 226 0.6× 111 1.1× 97 1.1× 38 0.7× 51 1.1× 14 328
Aleksandra Novikov United States 4 286 0.8× 190 1.8× 112 1.3× 31 0.6× 21 0.4× 4 387
Chii-Yuan Jeng Taiwan 11 197 0.6× 88 0.8× 95 1.1× 55 1.0× 93 2.0× 18 431
Nils Ekström Sweden 9 274 0.8× 59 0.6× 178 2.1× 26 0.5× 24 0.5× 11 373

Countries citing papers authored by Ana Pokrajac

Since Specialization
Citations

This map shows the geographic impact of Ana Pokrajac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Pokrajac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Pokrajac more than expected).

Fields of papers citing papers by Ana Pokrajac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Pokrajac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Pokrajac. The network helps show where Ana Pokrajac may publish in the future.

Co-authorship network of co-authors of Ana Pokrajac

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Pokrajac. A scholar is included among the top collaborators of Ana Pokrajac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Pokrajac. Ana Pokrajac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Banerjee, Debasish, Peter Winocour, Tahseen A Chowdhury, et al.. (2022). Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021. Kidney International Reports. 7(4). 681–687. 14 indexed citations
3.
Karalliedde, Janaka, Peter Winocour, Tahseen A Chowdhury, et al.. (2022). Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease. British Journal of Diabetes.
4.
Karalliedde, Janaka, Peter Winocour, Tahseen A Chowdhury, et al.. (2022). Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease. Diabetic Medicine. 39(4). e14769–e14769. 21 indexed citations
5.
Chowdhury, Tahseen A, Mona Wahba, Ritwika Mallik, et al.. (2021). Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation. Diabetic Medicine. 38(6). e14523–e14523. 29 indexed citations
6.
7.
Cunningham, Scott, et al.. (2019). My Diabetes My Way: clinical outcomes impact and user experiences for an electronic personal health record for diabetes. Future Healthcare Journal. 6(Suppl 1). s13–s13. 2 indexed citations
8.
Wilkinson, Samantha, Ian Douglas, Heide A. Stirnadel-Farrant, et al.. (2018). Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017. BMJ Open. 8(7). e022768–e022768. 80 indexed citations
9.
Pokrajac, Ana. (2018). APPG News. British Journal of Diabetes. 18(1). 46–47. 1 indexed citations
10.
Wilkinson, Samantha, Ian Douglas, Elizabeth Williamson, et al.. (2018). Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care. Clinical Epidemiology. Volume 10. 1639–1648. 13 indexed citations
11.
Winocour, Peter, Stephen C. Bain, Tahseen A Chowdhury, et al.. (2018). Managing hyperglycaemia in patients with diabetes and diabetic nephropathy–chronic kidney disease Summary of recommendations 2018. British Journal of Diabetes. 18(2). 78–89. 9 indexed citations
12.
13.
Pokrajac, Ana, Jan Frystyk, Allan Flyvbjerg, & Peter Trainer. (2009). Pituitary-independent effect of octreotide on IGF1 generation. European Journal of Endocrinology. 160(4). 543–548. 32 indexed citations
14.
Berg, Christian, Ana Pokrajac, Martin Bidlingmaier, et al.. (2008). Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF‐I in adults with severe GH deficiency (GHD). Clinical Endocrinology. 70(3). 439–445. 10 indexed citations
15.
Pokrajac, Ana, et al.. (2007). Variation in GH and IGF‐I assays limits the applicability of international consensus criteria to local practice. Clinical Endocrinology. 67(1). 65–70. 130 indexed citations
16.
Pokrajac, Ana, et al.. (2006). The octreotide test dose is not a reliable predictor of the subsequent response to somatostatin analogue therapy in patients with acromegaly. European Journal of Endocrinology. 154(2). 267–274. 23 indexed citations
17.
Žarković, Miloš, Svetlana Vujović, Jasmina Ćirić, et al.. (2005). Gonadotropin pulsatility in Cushing's syndrome compared with polycystic ovary syndrome. Gynecological Endocrinology. 20(3). 150–154. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yufeng Li Breakdown of academic impact, for papers by Abhishek Kansara Breakdown of academic impact, for papers by Shinji Kamei Breakdown of academic impact, for papers by Aydın Tunçkale Breakdown of academic impact, for papers by Steven Sambevski Breakdown of academic impact, for papers by Zhenwei Fang Breakdown of academic impact, for papers by Aleksandra Novikov Breakdown of academic impact, for papers by Chii-Yuan Jeng Breakdown of academic impact, for papers by Nils Ekström
Rankless by CCL
2026